Variant & Polymorphism
other
| polymorphism CYP3A4V potentially increased susceptibility to prostate cancer |
|
CYP3A4-W genotype may be at increased risk for treatment-related leukemia |
|
CYP3A4-W genotype may increase production of potentially DNA-damaging reactive intermediates and may decrease production of the epipodophyllotoxin catechol metabolite, which is the precursor of the potentially DNA-damaging quinone |
|
CYP3A4 and CYP3A5 polymorphisms were significantly associated with an increased risk of prostate cancer |
|
|